<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
17856-0675-1
</NDCCode>
<PackageDescription>
72 CUP, UNIT-DOSE in 1 CUP, UNIT-DOSE (17856-0675-1) / 5 mL in 1 CUP, UNIT-DOSE (17856-0675-2)
</PackageDescription>
<NDC11Code>
17856-0675-01
</NDC11Code>
<ProductNDC>
17856-0675
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Valproic Acid
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Valproic Acid
</NonProprietaryName>
<DosageFormName>
SOLUTION
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20190521
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA075379
</ApplicationNumber>
<LabelerName>
ATLANTIC BIOLOGICALS CORP.
</LabelerName>
<SubstanceName>
VALPROIC ACID
</SubstanceName>
<StrengthNumber>
250
</StrengthNumber>
<StrengthUnit>
mg/5mL
</StrengthUnit>
<Pharm_Classes>
Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2026-01-01
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20251231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20240521
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>